Southbridge Agrees To Acquire Vodis Innovative Pharmaceuticals Inc

Further to the news release of June 30, 2014, Southbridge Resources Corp. (“Southbridge”) is pleased to announce that it has received shareholder consent to the acquisition of Vodis Innovative Pharmaceuticals Inc. and expects the transaction to close within a week. Upon closing, the Company will change its name to Vodis Pharmaceuticals Inc. and begin trading under the symbol “VP”.

Vodis Pharmaceuticals Inc. intends to undertake a financing to raise additional working capital to pursue the expansion of its business model and is reviewing other opportunities related to the business model.


On Behalf of the Board of Directors,


Southbridge Resources Corp.



“Martin Cotter” President


Completion of the transaction is subject to a number of conditions, including Canadian Securities Exchange (`CSE`) acceptance. There can be no assurance that the transaction will be completed as proposed or at all.

Trading in the securities of Southbridge Resources Corp. should be considered highly speculative.

The CSE has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.

Cautionary Statement: Certain information contained in this press release constitutes “forward-looking information", within the meaning of Canadian legislation. Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", “forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur", "be achieved" or “has the potential to”. Forward looking statements contained in this press release may include statements regarding the potential spin-out and acquisition which involve known and unknown risks and uncertainties which may not prove to be accurate. Actual results and outcomes may differ materially from what is expressed or forecasted in these forward-looking statements. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States of America. The securities have not been and will not be registered under the United States Securities Act of 1933 (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons (as defined in the U.S. Securities Act) unless registered under the U.S. Securities Act and applicable state securities laws, or an exemption from such registration is available.

Vodis Corporate

  • Page 1 of 61